Iovance Biotherapeutics
IOVA
$11.08
Share price
-17.62%
Change (1 day)
50.54%
Change (1 year)
Categories
Iovance Biotherapeutics (IOVA) - Total debt
Total debt on the balance sheet as of December 2023 : $75.86 M
According to Iovance Biotherapeutics 's latest financial reports the company's total debt is $75.86 M. A company’s total debt is the sum of all current and non-current debts.
Iovance Biotherapeutics - Total debt on balance sheet (from 2011 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $75.86 M | -11.22% |
| 2022-12-31 | $85.44 M | 19.45% |
| 2021-12-31 | $71.53 M | 38.47% |
| 2020-12-31 | $51.65 M | 349.21% |
| 2019-12-31 | $11.5 M | |
| 2018-12-31 | $N/A | |
| 2012-12-31 | $6.48 M | 29.63% |
| 2011-12-31 | $5 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.8 M | -98.94% | Bahamas |
 NRC Health
NRC | $36.68 M | -51.64% | 🇺🇸 USA |